News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
96,718 Results
Type
Article (7090)
Company Profile (39)
Press Release (89587)
Multimedia
Podcasts (12)
Webinars (2)
Section
Business (28285)
Career Advice (127)
Deals (4090)
Drug Delivery (33)
Drug Development (14430)
Employer Resources (12)
FDA (2975)
Job Trends (2138)
News (50274)
Policy (6187)
Tag
Academia (434)
Accelerated approval (7)
Adcomms (7)
Allergies (35)
Alliances (9237)
ALS (21)
Alzheimer's disease (303)
Antibody-drug conjugate (ADC) (60)
Approvals (2942)
Artificial intelligence (72)
Autoimmune disease (13)
Automation (6)
Bankruptcy (19)
Best Places to Work (1815)
BIOSECURE Act (16)
Biosimilars (97)
Biotechnology (27)
Bladder cancer (30)
Brain cancer (6)
Breast cancer (72)
Cancer (662)
Cardiovascular disease (36)
Career advice (111)
Career pathing (3)
CAR-T (32)
CDC (9)
Cell therapy (119)
Cervical cancer (4)
Clinical research (12002)
Collaboration (281)
Compensation (74)
Complete response letters (15)
COVID-19 (650)
CRISPR (9)
C-suite (81)
Cystic fibrosis (14)
Data (714)
Denatured (3)
Depression (10)
Diabetes (47)
Diagnostics (592)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (37)
Drug pricing (37)
Drug shortages (1)
Duchenne muscular dystrophy (56)
Earnings (10130)
Editorial (11)
Employer branding (3)
Employer resources (10)
Events (12419)
Executive appointments (152)
FDA (3514)
Frontotemporal dementia (3)
Funding (185)
Gene editing (31)
Generative AI (8)
Gene therapy (126)
GLP-1 (130)
Government (1403)
Grass and pollen (1)
Guidances (70)
Healthcare (1998)
HIV (9)
Huntington's disease (6)
IgA nephropathy (6)
Immunology and inflammation (68)
Immuno-oncology (6)
Indications (12)
Infectious disease (699)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (22)
Intellectual property (21)
Interviews (11)
IPO (1888)
IRA (16)
Job creations (389)
Job search strategy (107)
Kidney cancer (3)
Labor market (6)
Layoffs (64)
Leadership (1)
Legal (587)
Liver cancer (13)
Longevity (6)
Lung cancer (105)
Lymphoma (48)
Machine learning (4)
Management (2)
Manufacturing (174)
MASH (23)
Medical device (1204)
Medtech (1206)
Mergers & acquisitions (2347)
Metabolic disorders (124)
Multiple sclerosis (26)
NASH (2)
Neurodegenerative disease (30)
Neuropsychiatric disorders (1)
Neuroscience (427)
NextGen: Class of 2025 (703)
Non-profit (354)
Now hiring (12)
Obesity (48)
Opinion (54)
Ovarian cancer (33)
Pain (11)
Pancreatic cancer (24)
Parkinson's disease (20)
Partnered (4)
Patents (43)
Patient recruitment (40)
Peanut (22)
People (8220)
Pharmaceutical (11)
Pharmacy benefit managers (4)
Phase I (3936)
Phase II (5006)
Phase III (4413)
Pipeline (605)
Policy (95)
Postmarket research (303)
Preclinical (1556)
Press Release (66)
Prostate cancer (28)
Psychedelics (6)
Radiopharmaceuticals (40)
Rare diseases (117)
Real estate (942)
Recruiting (4)
Regulatory (5091)
Reports (11)
Research institute (398)
Resumes & cover letters (11)
Rett syndrome (1)
RNA editing (2)
RSV (16)
Schizophrenia (16)
Series A (41)
Series B (15)
Service/supplier (3)
Sickle cell disease (11)
Special edition (4)
Spinal muscular atrophy (22)
Sponsored (10)
Startups (592)
State (1)
Stomach cancer (4)
Supply chain (12)
Tariffs (17)
The Weekly (9)
Vaccines (253)
Venture capital (11)
Weight loss (20)
Women's health (3)
Date
Last 7 days (97)
Last 30 days (455)
Last 365 days (5991)
2025 (4019)
2024 (6547)
2023 (7032)
2022 (9178)
2021 (9597)
2020 (8316)
2019 (5968)
2018 (4594)
2017 (5126)
2016 (4688)
2015 (5350)
2014 (3777)
2013 (2947)
2012 (3048)
2011 (3246)
2010 (2639)
Location
Africa (95)
Alabama (16)
Alaska (1)
Arizona (14)
Arkansas (2)
Asia (8586)
Australia (897)
California (1613)
Canada (325)
China (257)
Colorado (38)
Connecticut (37)
Delaware (68)
Europe (14344)
Florida (212)
Georgia (28)
Idaho (13)
Illinois (71)
India (17)
Indiana (42)
Iowa (7)
Japan (53)
Kansas (4)
Kentucky (11)
Louisiana (2)
Maine (5)
Maryland (372)
Massachusetts (1162)
Michigan (28)
Minnesota (59)
Mississippi (2)
Missouri (18)
Montana (5)
Nebraska (1)
Nevada (7)
New Hampshire (3)
New Jersey (587)
New Mexico (4)
New York (450)
North Carolina (236)
North Dakota (9)
Northern California (709)
Ohio (47)
Oklahoma (7)
Oregon (4)
Pennsylvania (248)
Puerto Rico (1)
Rhode Island (6)
South America (139)
South Carolina (3)
Southern California (679)
Tennessee (4)
Texas (230)
United States (5655)
Utah (30)
Virginia (22)
Washington D.C. (7)
Washington State (124)
West Virginia (1)
Wisconsin (12)
96,718 Results for "sino biological".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Merck, AstraZeneca Cancer Collaborator Gets Swallowed Up by Sino Biopharm
Shanghai-based LaNova Medicines—which has captured the attention of some of the biggest Western pharmas—will be folded into fellow Chinese company Sino Biopharmaceutical in a deal worth up to $951 million.
July 16, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Sino Biological Sets New Industry Standard with ProPure™ Endotoxin-Free Proteins Made in the USA
July 11, 2025
·
2 min read
Sponsored
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological
Sino Biological, Inc. has successfully concluded the acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc.
July 15, 2024
·
3 min read
Sponsored
Sino Biological’s New Center for Bioprocessing (C4B): US-Based CRO Services
In October 2023,
Sino Biological, Inc.
opened its
Center for Bioprocessing (C4B)
in Houston, Texas. The C4B represents a considerable global expansion of the company’s contract research service capabilities.
September 9, 2024
·
3 min read
Deals
Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio
Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), specializing in...
April 26, 2024
·
4 min read
Press Releases
Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV
March 10, 2025
·
4 min read
Business
Sino Biological Announces Services Partnership with Rapid Novor
Sino Biological, Inc., a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext, which provides biological research reagents and related technical contract research services, is pleased to announce the formation of a services partnership with Toronto, Canada-based Rapid Novor, Inc.
March 14, 2024
·
3 min read
Press Releases
Sino Biological and BioGeometry Deepen Strategic Cooperation to Empower Protein R&D with Generative AI
September 12, 2024
·
4 min read
Business
Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing
Sino Biological, Inc. is pleased to announce the formal opening of its new Center for Bioprocessing (C4B) in Houston, Texas USA at Levit Green, adjacent to the world-renowned Texas Medical Center.
October 9, 2023
·
3 min read
FDA
After Prasad’s Ouster, Makary Looks for Better Drug, Biologic Alignment at FDA
The FDA has denied that it plans to combine the Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research into one entity.
August 1, 2025
·
2 min read
·
Tristan Manalac
1 of 9,672
Next
